2023-2029 Global PD-1 and PD-L1 Drug Industry Research & Trends Analysis Report
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for PD-1 and PD-L1 Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China PD-1 and PD-L1 Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States PD-1 and PD-L1 Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, PD-1 Monoclonal Antibody segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Liver Cancer has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of PD-1 and PD-L1 Drug include Bristol Myers Squibb, Merck & Co., Inc., F. Hoffmann -La Roche Ltd, AstraZeneca, Sanofi, Pfizer Inc, Lilly, Novartis AG and GSK, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
PD-1/PD-L1 is an important part of the human immune system-a drug target on T cells. Drugs designed for this target can activate the immune effect of T cells on tumor cells, thereby awakening the patient's own anti-cancer effect. tumor effect.
This report aims to provide a comprehensive study of the global market for PD-1 and PD-L1 Drug. Report Highlights:
(1) Global PD-1 and PD-L1 Drug market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global PD-1 and PD-L1 Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China PD-1 and PD-L1 Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global PD-1 and PD-L1 Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global PD-1 and PD-L1 Drug segment by type and by application and regional segment by type and by application.
(6) Global major production regions of PD-1 and PD-L1 Drug, capacity, production and trends.
(7) PD-1 and PD-L1 Drug industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
PD-1 Monoclonal Antibody
PD-L1 Monoclonal Antibody
Market segment by application, can be divided into
Liver Cancer
Esophageal Cancer
Nasal Cancer
Stomach Cancer
Other
Market segment by players, this report covers
Bristol Myers Squibb
Merck & Co., Inc.
F. Hoffmann -La Roche Ltd
AstraZeneca
Sanofi
Pfizer Inc
Lilly
Novartis AG
GSK
Junshi Biosciences
Akeso, Inc
BeiGene
Innovent
Jiangsu Hengrui Medicine Co.,Ltd
Cstone
Henlius
Simcere Pharmaceutical Group Limited
1 Market Overview
1.1 PD-1 and PD-L1 Drug Definition
1.2 Global PD-1 and PD-L1 Drug Market Size and Forecast
1.2.1 By Revenue, Global PD-1 and PD-L1 Drug Market Size, 2018-2029
1.2.2 By Sales Volume, Global PD-1 and PD-L1 Drug Market Size, 2018-2029
1.2.3 Global PD-1 and PD-L1 Drug Price Trend, 2018-2029
1.3 China PD-1 and PD-L1 Drug Market Size and Forecast
1.3.1 By Revenue, China PD-1 and PD-L1 Drug Market Size, 2018-2029
1.3.2 By Sales Volume, China PD-1 and PD-L1 Drug Market Size, 2018-2029
1.3.3 China PD-1 and PD-L1 Drug Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China PD-1 and PD-L1 Drug Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China PD-1 and PD-L1 Drug Share in Global Market, 2018-2029
1.4.3 PD-1 and PD-L1 Drug Market Size: China VS Global, 2018-2029
1.5 PD-1 and PD-L1 Drug Market Dynamics
1.5.1 PD-1 and PD-L1 Drug Market Drivers
1.5.2 PD-1 and PD-L1 Drug Market Restraints
1.5.3 PD-1 and PD-L1 Drug Industry Trends
1.5.4 PD-1 and PD-L1 Drug Industry Policy
2 Global Competitive Landscape by Company
2.1 Global PD-1 and PD-L1 Drug Revenue by Company, 2018-2023
2.2 Global PD-1 and PD-L1 Drug Sales Volume by Company, 2018-2023
2.3 Global PD-1 and PD-L1 Drug Price by Company, 2018-2023
2.4 Global PD-1 and PD-L1 Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global PD-1 and PD-L1 Drug Concentration Ratio
2.6 Global PD-1 and PD-L1 Drug Mergers & Acquisitions, Expansion Plans
2.7 Global PD-1 and PD-L1 Drug Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China PD-1 and PD-L1 Drug Revenue by Company, 2018-2023
3.2 China PD-1 and PD-L1 Drug Sales Volume by Company, 2018-2023
3.3 China PD-1 and PD-L1 Drug PD-1 and PD-L1 Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China PD-1 and PD-L1 Drug Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, PD-1 and PD-L1 Drug Domestic VS Export
3.6 China Market, PD-1 and PD-L1 Drug Import & Export
3.6.1 China Market, PD-1 and PD-L1 Drug Import & Export, 2018-2029
3.6.2 China PD-1 and PD-L1 Drug Import & Export Trends
3.6.3 Main Sources of China PD-1 and PD-L1 Drug Import
3.6.4 Export Destination of China PD-1 and PD-L1 Drug
4 PD-1 and PD-L1 Drug Production by Region
4.1 Global PD-1 and PD-L1 Drug Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of PD-1 and PD-L1 Drug Manufacturers
4.3 Global Major Manufacturers, PD-1 and PD-L1 Drug Capacity Expansion and Future Plans
4.4 Global PD-1 and PD-L1 Drug Capacity by Region
4.5 Global PD-1 and PD-L1 Drug Production by Region
4.5.1 Global PD-1 and PD-L1 Drug Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global PD-1 and PD-L1 Drug Production by Region, 2018-2023
4.5.3 Global PD-1 and PD-L1 Drug Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 PD-1 and PD-L1 Drug Industry Chain
5.2 PD-1 and PD-L1 Drug Upstream Analysis
5.2.1 PD-1 and PD-L1 Drug Core Raw Materials
5.2.2 Main Manufacturers of PD-1 and PD-L1 Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 PD-1 and PD-L1 Drug Production Mode
5.6 PD-1 and PD-L1 Drug Procurement Model
5.7 PD-1 and PD-L1 Drug Industry Sales Model and Sales Channels
5.7.1 PD-1 and PD-L1 Drug Sales Model
5.7.2 PD-1 and PD-L1 Drug Typical Distributors
6 Sights by Type
6.1 PD-1 and PD-L1 Drug Classification
6.1.1 PD-1 Monoclonal Antibody
6.1.2 PD-L1 Monoclonal Antibody
6.2 By Type, Global PD-1 and PD-L1 Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global PD-1 and PD-L1 Drug Revenue, 2018-2029
6.4 By Type, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029
6.5 By Type, Global PD-1 and PD-L1 Drug Price, 2018-2029
7 Sights by Application
7.1 PD-1 and PD-L1 Drug Segment by Application
7.1.1 Liver Cancer
7.1.2 Esophageal Cancer
7.1.3 Nasal Cancer
7.1.4 Stomach Cancer
7.1.5 Other
7.2 By Application, Global PD-1 and PD-L1 Drug Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global PD-1 and PD-L1 Drug Revenue, 2018-2029
7.4 By Application, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029
7.5 By Application, Global PD-1 and PD-L1 Drug Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global PD-1 and PD-L1 Drug Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global PD-1 and PD-L1 Drug Revenue, 2018-2029
8.3 By Region, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029
8.4 North America
8.4.1 North America PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America PD-1 and PD-L1 Drug Market Size Market Share
8.5 Europe
8.5.1 Europe PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe PD-1 and PD-L1 Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific PD-1 and PD-L1 Drug Market Size Market Share
8.7 South America
8.7.1 South America PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America PD-1 and PD-L1 Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global PD-1 and PD-L1 Drug Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global PD-1 and PD-L1 Drug Revenue, 2018-2029
9.3 By Country, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. PD-1 and PD-L1 Drug Market Size, 2018-2029
9.4.2 By Company, U.S. PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.4.3 By Type, U.S. PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe PD-1 and PD-L1 Drug Market Size, 2018-2029
9.5.2 By Company, Europe PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.5.3 By Type, Europe PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China PD-1 and PD-L1 Drug Market Size, 2018-2029
9.6.2 By Company, China PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.6.3 By Type, China PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.6.4 By Application, China PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan PD-1 and PD-L1 Drug Market Size, 2018-2029
9.7.2 By Company, Japan PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.7.3 By Type, Japan PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea PD-1 and PD-L1 Drug Market Size, 2018-2029
9.8.2 By Company, South Korea PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.8.3 By Type, South Korea PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia PD-1 and PD-L1 Drug Market Size, 2018-2029
9.9.2 By Company, Southeast Asia PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India PD-1 and PD-L1 Drug Market Size, 2018-2029
9.10.2 By Company, India PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.10.3 By Type, India PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.10.4 By Application, India PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia PD-1 and PD-L1 Drug Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position
10.1.2 Bristol Myers Squibb PD-1 and PD-L1 Drug Models, Specifications and Application
10.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Bristol Myers Squibb Company Profile and Main Business
10.1.5 Bristol Myers Squibb Recent Developments
10.2 Merck & Co., Inc.
10.2.1 Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position
10.2.2 Merck & Co., Inc. PD-1 and PD-L1 Drug Models, Specifications and Application
10.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Merck & Co., Inc. Company Profile and Main Business
10.2.5 Merck & Co., Inc. Recent Developments
10.3 F. Hoffmann -La Roche Ltd
10.3.1 F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area and Industry Position
10.3.2 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Models, Specifications and Application
10.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 F. Hoffmann -La Roche Ltd Company Profile and Main Business
10.3.5 F. Hoffmann -La Roche Ltd Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.4.2 AstraZeneca PD-1 and PD-L1 Drug Models, Specifications and Application
10.4.3 AstraZeneca PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 AstraZeneca Company Profile and Main Business
10.4.5 AstraZeneca Recent Developments
10.5 Sanofi
10.5.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.5.2 Sanofi PD-1 and PD-L1 Drug Models, Specifications and Application
10.5.3 Sanofi PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Sanofi Company Profile and Main Business
10.5.5 Sanofi Recent Developments
10.6 Pfizer Inc
10.6.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.6.2 Pfizer Inc PD-1 and PD-L1 Drug Models, Specifications and Application
10.6.3 Pfizer Inc PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Pfizer Inc Company Profile and Main Business
10.6.5 Pfizer Inc Recent Developments
10.7 Lilly
10.7.1 Lilly Company Information, Head Office, Market Area and Industry Position
10.7.2 Lilly PD-1 and PD-L1 Drug Models, Specifications and Application
10.7.3 Lilly PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Lilly Company Profile and Main Business
10.7.5 Lilly Recent Developments
10.8 Novartis AG
10.8.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.8.2 Novartis AG PD-1 and PD-L1 Drug Models, Specifications and Application
10.8.3 Novartis AG PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Novartis AG Company Profile and Main Business
10.8.5 Novartis AG Recent Developments
10.9 GSK
10.9.1 GSK Company Information, Head Office, Market Area and Industry Position
10.9.2 GSK PD-1 and PD-L1 Drug Models, Specifications and Application
10.9.3 GSK PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 GSK Company Profile and Main Business
10.9.5 GSK Recent Developments
10.10 Junshi Biosciences
10.10.1 Junshi Biosciences Company Information, Head Office, Market Area and Industry Position
10.10.2 Junshi Biosciences PD-1 and PD-L1 Drug Models, Specifications and Application
10.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Junshi Biosciences Company Profile and Main Business
10.10.5 Junshi Biosciences Recent Developments
10.11 Akeso, Inc
10.11.1 Akeso, Inc Company Information, Head Office, Market Area and Industry Position
10.11.2 Akeso, Inc PD-1 and PD-L1 Drug Models, Specifications and Application
10.11.3 Akeso, Inc PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Akeso, Inc Company Profile and Main Business
10.11.5 Akeso, Inc Recent Developments
10.12 BeiGene
10.12.1 BeiGene Company Information, Head Office, Market Area and Industry Position
10.12.2 BeiGene PD-1 and PD-L1 Drug Models, Specifications and Application
10.12.3 BeiGene PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 BeiGene Company Profile and Main Business
10.12.5 BeiGene Recent Developments
10.13 Innovent
10.13.1 Innovent Company Information, Head Office, Market Area and Industry Position
10.13.2 Innovent PD-1 and PD-L1 Drug Models, Specifications and Application
10.13.3 Innovent PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Innovent Company Profile and Main Business
10.13.5 Innovent Recent Developments
10.14 Jiangsu Hengrui Medicine Co.,Ltd
10.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Information, Head Office, Market Area and Industry Position
10.14.2 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Models, Specifications and Application
10.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Jiangsu Hengrui Medicine Co.,Ltd Company Profile and Main Business
10.14.5 Jiangsu Hengrui Medicine Co.,Ltd Recent Developments
10.15 Cstone
10.15.1 Cstone Company Information, Head Office, Market Area and Industry Position
10.15.2 Cstone PD-1 and PD-L1 Drug Models, Specifications and Application
10.15.3 Cstone PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Cstone Company Profile and Main Business
10.15.5 Cstone Recent Developments
10.16 Henlius
10.16.1 Henlius Company Information, Head Office, Market Area and Industry Position
10.16.2 Henlius PD-1 and PD-L1 Drug Models, Specifications and Application
10.16.3 Henlius PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Henlius Company Profile and Main Business
10.16.5 Henlius Recent Developments
10.17 Simcere Pharmaceutical Group Limited
10.17.1 Simcere Pharmaceutical Group Limited Company Information, Head Office, Market Area and Industry Position
10.17.2 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Models, Specifications and Application
10.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Simcere Pharmaceutical Group Limited Company Profile and Main Business
10.17.5 Simcere Pharmaceutical Group Limited Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. PD-1 and PD-L1 Drug Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. PD-1 and PD-L1 Drug Market Restraints
Table 3. PD-1 and PD-L1 Drug Market Trends
Table 4. PD-1 and PD-L1 Drug Industry Policy
Table 5. Global PD-1 and PD-L1 Drug Revenue by Company, 2018-2023, US$ million
Table 6. Global PD-1 and PD-L1 Drug Revenue Market Share by Company, 2018-2023
Table 7. Global PD-1 and PD-L1 Drug Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global PD-1 and PD-L1 Drug Sales Volume Market Share by Company, 2018-2023
Table 9. Global PD-1 and PD-L1 Drug Price by Company, 2018-2023, (US$/Unit)
Table 10. Global PD-1 and PD-L1 Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global PD-1 and PD-L1 Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global PD-1 and PD-L1 Drug Manufacturers Product Type
Table 13. China PD-1 and PD-L1 Drug Revenue by Company, 2018-2023, US$ million
Table 14. China PD-1 and PD-L1 Drug Revenue Market Share by Company, 2018-2023
Table 15. China PD-1 and PD-L1 Drug Sales Volume by Company, 2018-2023, (K Units)
Table 16. China PD-1 and PD-L1 Drug Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, PD-1 and PD-L1 Drug Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China PD-1 and PD-L1 Drug Import & Export Trends
Table 19. Main Sources of China PD-1 and PD-L1 Drug Import
Table 20. Export Destination of China PD-1 and PD-L1 Drug
Table 21. Global Headquarters and Manufacturing Base of PD-1 and PD-L1 Drug Manufacturers
Table 22. Global Major Manufacturers, PD-1 and PD-L1 Drug Capacity Expansion and Future Plans
Table 23. Global PD-1 and PD-L1 Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global PD-1 and PD-L1 Drug Production by Region, 2018-2023, (K Units)
Table 25. Global PD-1 and PD-L1 Drug Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of PD-1 and PD-L1 Drug Upstream (Raw Materials)
Table 27. Global PD-1 and PD-L1 Drug Typical Customers
Table 28. PD-1 and PD-L1 Drug Typical Distributors
Table 29. By Type, Global PD-1 and PD-L1 Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global PD-1 and PD-L1 Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global PD-1 and PD-L1 Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global PD-1 and PD-L1 Drug Revenue, 2018-2029, US$ Million
Table 33. By Region, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global PD-1 and PD-L1 Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global PD-1 and PD-L1 Drug Revenue, 2018-2029, US$ Million
Table 36. By Country, Global PD-1 and PD-L1 Drug Revenue Market Share, 2018-2029
Table 37. By Country, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global PD-1 and PD-L1 Drug Sales Volume Market Share, 2018-2029
Table 39. Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position
Table 40. Bristol Myers Squibb PD-1 and PD-L1 Drug Models, Specifications and Application
Table 41. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Bristol Myers Squibb Company Profile and Main Business
Table 43. Bristol Myers Squibb Recent Developments
Table 44. Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position
Table 45. Merck & Co., Inc. PD-1 and PD-L1 Drug Models, Specifications and Application
Table 46. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Merck & Co., Inc. Company Profile and Main Business
Table 48. Merck & Co., Inc. Recent Developments
Table 49. F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 50. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Models, Specifications and Application
Table 51. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. F. Hoffmann -La Roche Ltd Company Profile and Main Business
Table 53. F. Hoffmann -La Roche Ltd Recent Developments
Table 54. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 55. AstraZeneca PD-1 and PD-L1 Drug Models, Specifications and Application
Table 56. AstraZeneca PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. AstraZeneca Company Profile and Main Business
Table 58. AstraZeneca Recent Developments
Table 59. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 60. Sanofi PD-1 and PD-L1 Drug Models, Specifications and Application
Table 61. Sanofi PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Sanofi Company Profile and Main Business
Table 63. Sanofi Recent Developments
Table 64. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 65. Pfizer Inc PD-1 and PD-L1 Drug Models, Specifications and Application
Table 66. Pfizer Inc PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Pfizer Inc Company Profile and Main Business
Table 68. Pfizer Inc Recent Developments
Table 69. Lilly Company Information, Head Office, Market Area and Industry Position
Table 70. Lilly PD-1 and PD-L1 Drug Models, Specifications and Application
Table 71. Lilly PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Lilly Company Profile and Main Business
Table 73. Lilly Recent Developments
Table 74. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 75. Novartis AG PD-1 and PD-L1 Drug Models, Specifications and Application
Table 76. Novartis AG PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Novartis AG Company Profile and Main Business
Table 78. Novartis AG Recent Developments
Table 79. GSK Company Information, Head Office, Market Area and Industry Position
Table 80. GSK PD-1 and PD-L1 Drug Models, Specifications and Application
Table 81. GSK PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. GSK Company Profile and Main Business
Table 83. GSK Recent Developments
Table 84. Junshi Biosciences Company Information, Head Office, Market Area and Industry Position
Table 85. Junshi Biosciences PD-1 and PD-L1 Drug Models, Specifications and Application
Table 86. Junshi Biosciences PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Junshi Biosciences Company Profile and Main Business
Table 88. Junshi Biosciences Recent Developments
Table 89. Akeso, Inc Company Information, Head Office, Market Area and Industry Position
Table 90. Akeso, Inc PD-1 and PD-L1 Drug Models, Specifications and Application
Table 91. Akeso, Inc PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Akeso, Inc Company Profile and Main Business
Table 93. Akeso, Inc Recent Developments
Table 94. BeiGene Company Information, Head Office, Market Area and Industry Position
Table 95. BeiGene PD-1 and PD-L1 Drug Models, Specifications and Application
Table 96. BeiGene PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. BeiGene Company Profile and Main Business
Table 98. BeiGene Recent Developments
Table 99. Innovent Company Information, Head Office, Market Area and Industry Position
Table 100. Innovent PD-1 and PD-L1 Drug Models, Specifications and Application
Table 101. Innovent PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Innovent Company Profile and Main Business
Table 103. Innovent Recent Developments
Table 104. Jiangsu Hengrui Medicine Co.,Ltd Company Information, Head Office, Market Area and Industry Position
Table 105. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Models, Specifications and Application
Table 106. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Jiangsu Hengrui Medicine Co.,Ltd Company Profile and Main Business
Table 108. Jiangsu Hengrui Medicine Co.,Ltd Recent Developments
Table 109. Cstone Company Information, Head Office, Market Area and Industry Position
Table 110. Cstone PD-1 and PD-L1 Drug Models, Specifications and Application
Table 111. Cstone PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Cstone Company Profile and Main Business
Table 113. Cstone Recent Developments
Table 114. Henlius Company Information, Head Office, Market Area and Industry Position
Table 115. Henlius PD-1 and PD-L1 Drug Models, Specifications and Application
Table 116. Henlius PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Henlius Company Profile and Main Business
Table 118. Henlius Recent Developments
Table 119. Simcere Pharmaceutical Group Limited Company Information, Head Office, Market Area and Industry Position
Table 120. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Models, Specifications and Application
Table 121. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Simcere Pharmaceutical Group Limited Company Profile and Main Business
Table 123. Simcere Pharmaceutical Group Limited Recent Developments
List of Figure
Figure 1. PD-1 and PD-L1 Drug Picture
Figure 2. By Revenue, Global PD-1 and PD-L1 Drug Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global PD-1 and PD-L1 Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global PD-1 and PD-L1 Drug Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China PD-1 and PD-L1 Drug Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China PD-1 and PD-L1 Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China PD-1 and PD-L1 Drug Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China PD-1 and PD-L1 Drug Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China PD-1 and PD-L1 Drug Share of Global Market, 2018-2029
Figure 10. Global PD-1 and PD-L1 Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global PD-1 and PD-L1 Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China PD-1 and PD-L1 Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China PD-1 and PD-L1 Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China PD-1 and PD-L1 Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of PD-1 and PD-L1 Drug Domestic VS Export, 2022
Figure 16. Global PD-1 and PD-L1 Drug Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global PD-1 and PD-L1 Drug Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global PD-1 and PD-L1 Drug Production Market Share & Forecast by Region, 2018-2029
Figure 19. PD-1 and PD-L1 Drug Industry Chain
Figure 20. PD-1 and PD-L1 Drug Procurement Model
Figure 21. PD-1 and PD-L1 Drug Sales Model
Figure 22. PD-1 and PD-L1 Drug Sales Channels, Direct Sales and Distribution
Figure 23. PD-1 Monoclonal Antibody
Figure 24. PD-L1 Monoclonal Antibody
Figure 25. By Type, Global PD-1 and PD-L1 Drug Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global PD-1 and PD-L1 Drug Revenue Market Share, 2018-2029
Figure 27. By Type, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global PD-1 and PD-L1 Drug Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global PD-1 and PD-L1 Drug Price, 2018-2029, (US$/Unit)
Figure 30. Liver Cancer
Figure 31. Esophageal Cancer
Figure 32. Nasal Cancer
Figure 33. Stomach Cancer
Figure 34. Other
Figure 35. By Application, Global PD-1 and PD-L1 Drug Revenue, 2018-2029, US$ Million
Figure 36. By Application, Global PD-1 and PD-L1 Drug Revenue Market Share, 2018-2029
Figure 37. By Application, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 38. By Application, Global PD-1 and PD-L1 Drug Sales Volume Market Share, 2018-2029
Figure 39. By Application, Global PD-1 and PD-L1 Drug Price, 2018-2029, (US$/Unit)
Figure 40. By Region, Global PD-1 and PD-L1 Drug Revenue Market Share, 2018-2029
Figure 41. By Region, Global PD-1 and PD-L1 Drug Sales Volume Market Share, 2018-2029
Figure 42. North America PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America PD-1 and PD-L1 Drug Revenue Market Share, 2022
Figure 44. Europe PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe PD-1 and PD-L1 Drug Revenue Market Share, 2022
Figure 46. Asia Pacific PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific PD-1 and PD-L1 Drug Revenue Market Share, 2022
Figure 48. South America PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America PD-1 and PD-L1 Drug Revenue Market Share, 2022
Figure 50. Middle East & Africa PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 52. By Company, U.S. PD-1 and PD-L1 Drug Market Share, 2022
Figure 53. By Type, U.S. PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, Europe PD-1 and PD-L1 Drug Market Share, 2022
Figure 57. By Type, Europe PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 59. China PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, China PD-1 and PD-L1 Drug Market Share, 2022
Figure 61. By Type, China PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, Japan PD-1 and PD-L1 Drug Market Share, 2022
Figure 65. By Type, Japan PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 68. By Company,
Research Methodology:
Global PD 1 and PD L1 Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|